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Objective:Thepurposeofthisstudyistopresentamultifaceted,definitivereviewofthe
pastandcurrentstatusofsmokeinhalationinjury.Historyalongwithcurrentunderstand-
ing of anatomical, physiology, and biologic components will be discussed. Methods:
The literature has been reviewed from the early onset of the concept of smoke inhalation
in the 1920s to our current understanding as of 2007. Results: The results indicate that
the current pathophysiologic concept is of a disease process that leads to immediate and
delayedpulmonaryinjurybestmanagedbyaggressivephysiologicsupport.Management
approaches for the biochemical changes have not kept up with current knowledge. The
lung injury process is activated by toxins in the smoke’s gas and particle components
and perpetuated by a resulting lung inflammation. This inflammatory process becomes
self-perpetuating through the activation of a large number of inflammatory cascades. In
addition, smoke injury leads to significant systemic abnormalities injuring other organs
and accentuating the burn injury process and subsequently leading to mediator-induced
cellular injury leading potentially to multisystem organ failure. Conclusions: Smoke
inhalation injury results in the anatomic finding of denuded and sometimes sloughed
airways mucosa. Physiologic findings include small airways containing fibrin casts
of mucosa and neutrophils. Airway hyper-reactivity results as well, leading to further
decreased collapse, causing obstruction.
Smoke inhalation injury, either by itself or in the presence of a burn, is now well-
recognized to result in severe lung-induced morbidity and mortality. The most common
cause of death in burn centers is now respiratory failure.1–3
Overall,burntragediesinhistoryhavemarkedlyimprovedourknowledgeofthisinjury
(Table 1). Although smoke inhalation injury has been present since ancient times, it was
probably the use of chemical warfare agents in World War I that first initiated the interest.
In 1915, the German army released aerosolized chlorine into the air toward the Allied
troops.Theresponse,uponbreathing,wassevereairwayirritationwithcoughing,andsevere
exposure led to pulmonary edema and death. Filtering the gases with an activated charcoal
filter removed the chlorine from the air,4,5 a method of decreasing lung damage.
Phosgene gas, a component of smoke, was purified and also used as a chemical war-
fare agent along with mustard gas, also leading to lung damage.4 Phosgene is a common
component of smoke today in any fire.
254DEMLING
Table 1. Notable events leading to smoke inhalation knowledge
Event Characteristics
World War I Use of poisonous gases and the effect on the lungs
Cleveland Clinic Fire, 1929 Effect of the inhalation of volatile products from burning x-ray
film
Coconut Grove Fire, 1942 Effect of volatile products in smoke causing early and late
respiratory distress, initially from upper airway compromise and
then airway plugging
Mid-1940s World War II Pathophysiologic; time, course, and treatment using respiratory
assistance
1950s–1960s Development of blood–gas monitoring and intensive care
Vietnam War, 1960s Identification of adult respiratory distress syndrome caused by
alveolar capillary membrane damage
1970s Better understanding of smoke inhalation causing post-traumatic
pulmonary insufficiency (PTPI, ARDS), improved ventilator
management, and the toxicology of smoke
1980s–1990s casualties from hotel fire
in Las Vegas and Kings Cross
Underground Station Fire
Role of the effect of airway inflammation in smoke inhalation
injury
2000s mass casualties, World Trade
Center Disaster 2001
Long-term effects of smoke exposure changes in airways
epithelium
Rhode Island Nightclub Fire, 2003 Biochemical and cell biologic changes; improved ventilatory
strategies
The Cleveland Clinic Fire, in 1929, was caused by burning x-ray film. The cause of
the many respiratory deaths was considered to be the released toxin, nitrogen dioxide, again
a component of smoke in fires today.6
Skinburnswerefrequentlyabsentandmanagementofthelunginjurybecameapriority
forburnteams.Thepulmonarypathologyaftersmokeexposurewasconsideredtobeslough
ofthelarge-andsmall-airwaymucosacausingobstructiontobreathing.Itwasnotuntilafter
the Coconut Grove Night Club Fire in 1942 that a surge of research in the pathophysiology
of smoke inhalation developed.7,8 In this tragedy, hundreds of people were involved, many
dying rapidly from apparent respiratory failure in the absence of burns. Others initially
survived only to die later of what appeared to be pneumonia.7,8
Of importance was the fact that victims, not dead on arrival, appeared to be stable
until 12- to 24-hours later, at which point the respiratory distress developed.7−9 Bronchial
obstructions which developed, now recognized to be the result of the delayed airways mu-
cosal slough, were caused by toxins that carried carbonaceous particles. Carbon monoxide
poisoning was then well understood, so the initial use of oxygen was already established.9
By the mid-1940s, World War II was underway, and the risks of lung damage from
closed-space fires were well recognized. Dr Oliver Cope, at the Massachusetts General
Hospital, was instrumental in describing the pathology, time course, and the treatment of
the severe cases of smoke inhalation injury. Respiratory assistance was recognized as a key
factor in survival.9
Thelateeffectontheairwaysandalveoliofsmokeexposurewasnotyetappreciated,as
ventilator assistance was not yet a tool used for longer-term survival. It was not until the use
of blood-gas analysis in the late 1960s, that a clearer pattern of basic pathophysiology was
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determined along with the establishment of critical care medicine.10 The adult respiratory
distresssyndrome(ARDS)wasalsobecomingrecognizedinthe1960s,andalveolaredema
and collapse were recognized.11
Itwasstilltobedeterminedthatsmokeinhalationwasmainlyalarge-andsmall-airway
injury, although ARDS remained an alveolar damage process. Also, the role of bacteria in
the lungs after inhalation injury became better recognized.12,13
A burst of research activity from the late 1970s and early 1980s better defined the
chemical toxins found in smoke, including cyanide. Advances in the field of toxicology and
the composition of aerosols provided the tools for research in the area. Identification of gas
andparticlephasesofsmokeanditscomponentsallowedforfairlyaccuratecause-and-effect
hypotheses.11−16
Theadvanceswerefollowedbymoreactiveresearchonparticlesizeanddistributionin
the lung. It was not appreciated until later that the particles carried gas phase toxins, which
then deposited on the tracheal bronchial tree leading to the airways injury. The potentiating
effect of a smoke injury on burn morbidity and mortality was well described in the 1980s.
The mechanism of this potentiating effect still remains poorly understood.17−20
Overall, uncovering the physiologic changes in the lung evolved stepwise through
fairly recent history (Table 2).21−23
Through the 1990s to the present, the research focus in this area has been to better
define the biochemical and cell biologic changes, occurrence of which would explain the
recognized physiologic changes. The products of airway inflammation, characteristics of
smoke injury, have been of particular interest.24−29 Proinflammatory cytokines and free
oxygen radicals have been demonstrated to play a significant role in both the lung and
systemic response to smoke. More recently, apoptosis or programmed cell death has been
found in the injured airways epithelium.28
The Station Nightclub Fire in Rhode Island in 2005 and the 9/11 World Trade Center
tragedy in 2001 have led to a number of observations, stimulating further research.29,30
However, it is fair to state that the recently identified cell biologic and cell genetic
changes have not yet altered the clinical management. The identified physiologic changes
have,however,playedamajorroleinimprovingmanagement,therebyleadingtoadecrease
in mortality and morbidity.
COMMON COMPONENTS OF SMOKE
The composition of smoke, which leads to the lung injury, is described in this section.
Table 2. Historic progression of known physiologic changes in smoke injury
• Volatile products in smoke leading to early and late respiratory distress
• Airways edema leading to early destruction and later airways plugging
• Use of blood gases to assess the exchange of gases and critical care to stabilize lung physiology
• Ventilatory support to stabilize physiologic changes
• Concept of tracheobronchitis and alveolitis impairing ventilation and gas exchange
• Adult respiratory distress syndrome, alveolar edema and collapse, surfactant deficiency, increase in shunting
• Role of airways inflammation and mediators on the physiologic changes with smoke inhalation
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Figure 1. Effect of the components of smoke on the lungs. Water-soluble gases are
seen producing upper-airway irritation. The components on the carbon particles lead
to more severe airways damage including cell membrane changes and, in some cases,
alveolar damage. Carbon monoxide and cyanide are absorbed directly into the blood
from the alveoli.
Chemicals in smoke (Figure 1)
The majority of toxicology studies on smoke injury were performed in the 1970s and
1980s with little research since that time. There are a large number of well-described
components of smoke and descriptions of their effect on the pulmonary and sys-
temic physiologic components. The sources of these components are also described
(Table 331−35 and 4).
Table 3. Common components of smoke and their effect
Products in smoke Effect
Carbon dioxide Increased respiratory drive
Carbon monoxide Tissue hypoxia, organ failure, death
Hydrogen cyanide Tissue hypoxia, organ failure, death
Oxygen radicals Mucus membrane damage, alveolar damage
Acrolein or propenal Irritant to necrosing agent, involving airways mucosa death
Aldehydes, formaldehyde,
acetaldehyde, butyraldehyde Necrosing agent to mucosa, denatures protein
Ammonia Mucus membrane irritant, including airway muscosa
Sulfur dioxide Mucus membrane irritant
Hydrogen chloride (phosgene) Necrosing airway mucosa
Aromatic hydrocarbons, eg, benzene Mucus membrane irritant, systemic toxin
Hydrogen sulfide Mucus membrane irritant and corrosive
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Table 4. Origin of selected toxic compounds
Material Source Decomposition products
All combustible products Carbon monoxide, dioxide, oxygen
radicals
Cellulose Wood, paper, cotton Aldehydes, acrolein
Wool, silk Clothing, fabric, blankets, furniture Hydrogen cyanide, ammonia,
hydrogen sulfide
Rubber Tires Sulfur dioxide, hydrogen sulfide,
oxygen radicals
Polyvinyl chloride Upholstery, wire/pipe coating, wall,
floor, furniture coverings
Hydrogen chloride, phosgene
Polyurethane Insulation, upholstery material Hydrogen cyanide, isocyanates,
ammonia, acrylonitriles
Polyester Clothing, fabric Hydrogen chloride
Polypropylene Upholstery, carpeting Acrolein, oxygen radicals
Polyacrylonitrile Appliances, engineering, plastics Hydrogen cyanide
Polyamide Carpeting, clothing Hydrogen cyanide, ammonia
Polyamine resins Household and kitchen goods Hydrogen cyanide, ammonia,
formaldehyde
Acrylics Aircraft windows, textiles, wall
coverings
Acrolein, aldehydes
Fire retardants Polymeric materials Hydrogen cyanide, acetylene
chloroethane, propene nitrite
Carbon monoxide is released during combustion of any product. Carbon monox-
ide leads to generalized tissue hypoxia and possible death when combining with
hemoglobin.36,37
Carbon dioxide is also released, increasing respiratory drive and respiratory efforts.
Hydrogencyanideisreleasedfromanumberofproductsincludingpolyurethane,used
to insulate furniture and mattresses, as well as the burning of wool, silk, and carpets. The
cyanide binds to the cytochrome system and leads to tissue hypoxia and possible death.38,39
The combination of carbon monoxide and cyanide likely occurs in a typical closed-
space fire, especially with the increased use of household synthetics.40
Hydrogen chloride is released in large amounts with the combustion of polyvinyl, a
commoncompoundusedtocoverfurniture,floors,andupholstery.Itappearsthathydrochlo-
ricacidboundtoparticlesismuchmoretoxicthanthehydrochloricaciddissolvedinthegas.
Thehydrochloricacidcausesdestructionoftheairwaymucosaandresultsinacutebronchitis
(Table 5).40,41
Phosgeneisastrongpulmonaryirritant.Itisacolorlessgas,relativelywatersolublebut
also carried on particles. It is released with the combustion of polyvinyl chloride. Phosgene
is slowly hydrolyzed to hydrochloric acid and carbon dioxide. Primary sites of injury are
the small airways and alveoli.42
Acrolein, also called propenal, is a toxic compound released with burning of wood,
cotton, paper, and petroleum. It is the simplest aldehyde with a 3-carbon chain. Acrolein is
a very unstable compound that can bind to particles. Severe upper respiratory irritation can
occur, and it is also toxic to lower airways mucosa. Sudden death in less than 10 minutes
will occur with breathing concentrations of over 50 ppm.43,44
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Table 5. Effects of inhalation of hydrogen chloride on humans
Hydrogen chloride
concentration in air, ppm Symptoms
1–5 Limit of odor
5–10 Mild irritation of mucus membranes
35 Irritation of throat on short exposure
50–100 Barely tolerable
1000 Lung edema after short exposure
Other aldehydes like formaldehyde are released with combustion of a large number
of synthetics and woods. These compounds are corrosive and denature tissue proteins.
Formaldehyde also denatures RNA. These agents are some of the most toxic components
of smoke.
Free radicals, especially oxygen-free radicals, are released from virtually all burning
products, especially wood and rubber. These compounds are highly reactive and, therefore,
toxic to tissues. Peroxidation of the outer lipid layer of the cell is one of the results, leading
tocelldamageandcelldeath.Long-actingfreeradicalsaregeneratedbychemicalreactions
in the smoke itself. Radicals that can last more than 20 minutes are also responsible for
accentuating inflammation.3,45−48
Ammonia is an irritant compound released in gas phase with the combustion of many
synthetic products leading to tearing, cough, increased secretions and bronchoconstriction.
Ammonia also forms ammonium hydroxide, a potent alkali leading to tissue necrosis when
carried by particles to lower airways.42−49
Sulfurdioxideisacompoundreleasedmainlythroughtheburningofrubberproducts.
It is very irritating to the airway mucosa and the eyes at relatively low concentrations. High
concentrations will be fatal. It is oxidized to sulfurous acid and sulfuric acid. Toxicity is
increased when dissolved onto soot particles. It is associated with lower-airways injury and
lung edema.49,50
Nitrogen dioxide is the most important nitrogen oxide. NO2 is a gas with limited
solubility in water and can be carried by particles. It is produced by the combustion of
fabrics and cellulose products. The injury is mainly to lower airways and is delayed in onset
up to 72 hours. Lipid solubility leads to damage to all membranes and cell death. Excessive
damage to airways and alveolar epithelium is noted.49,50
Chlorine is an intensely irritating compound that, when dissolved in water on the
mucosal surface, forms hydrochloride and hydrochlorus acid. Oxygen radicals are also
released; chlorine (Cl2) is released with combustion of plastics and resins and is a common
bleaching agent. Chlorine is believed to cause damage to tissues because of its very potent
oxidizing properties. Intense bronchospasm as well as cell necrosis results.42,49
Fire retardants are usually polymeric products with the insertion of halogens and
phosphorous. They are used in mattresses and furniture. Combustion leads to the release of
cyanide, acetylene, methane, and a variety of toxins that can damage mucosal surfaces as
well as have systemic effects.
Aromatic hydrocarbons, like benzene, seen mainly as organic polymers, become
volatile unsaturated hydrocarbons on burning leading to local airway irritability and sys-
temic toxicity.
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Table 6. Relationship of CO in smoke to percent COHgb
CO concentration, ppm Smoke characteristics Time to 20% COHgb
10,000 Heavy smoke <5 min
5,000 Moderate <10 min
2,000 Mild smoke 20 min
Interestingly, the majority of the studies assessing smoke toxicity were performed in
the 1970s and 1980s, and there has not been much toxicity research since then.
Carbon monoxide and cyanide toxicity
Carbon monoxide toxicity is one of the leading causes of death in fires. Whereas oxygen
is used during combustion, carbon monoxide is released, because it is a basic by-product
of combustion.16,41 Carbon monoxide is rapidly transported across the alveolar membrane
and preferentially binds with the hemoglobin molecule in place of oxygen. In addition,
carbon monoxide shifts the hemoglobin-oxygen dissociation curve to the left, thereby im-
pairing oxygen unloading at the tissue level. The result is a major impairment in oxygen
delivery.51−53
TheabsorptionofCOisdependentonitsconcentrationinthesmokeexposure.Table6
showstheanticipatedconcentrationofCOinlight,moderate,andheavysmoke.Withheavy
smoke, the time to toxicity (CO level of 20%) is less than a 5-minute exposure.
Production of hydrocyanide, the gaseous form of cyanide, is also a well-recognized
causeofmorbidityandmortality,especiallywithburningofsyntheticssuchaspolyurethane.
The combination of carbon monoxide and cyanide as a cause of death is quite common.16
Although cyanide can be absorbed through the gastrointestinal tract or skin, it is most
dangerous when aerosolized and inhaled because of its rapid absorption through the large
surface area of the lung. The hydrocyanide then binds to the cytochrome system, thereby
inhibitingcellmetabolismandadenosinetriphosphateproduction.Allcellsandinparticular
theliverhaveadetoxifyingprocessforhydrocyanidewiththeenzymerhodenaseconverting
hydrocyanidetothiocyanate,whichisthenexcretedintheurine.Thisprotectivesystemcan
be overcome by a large amount of cyanide, especially if the patient is also hypovolemic,
thereby impairing cyanide metabolism and clearance.15,53
SYMPTOMS
Symptoms of carbon monoxide toxicity are usually present when carboxyhemoglobin level
exceeds15%,thatis,15%ofthehemoglobinisboundtocarbonmonoxideratherthanoxygen
(Table 7). Symptoms are those of decreased tissue oxygenation, with initial manifestations
being neurologic.
Major myocardial dysfunction can also develop, especially with preexisting coronary
artery disease. In addition, neurologic exposure, by carbon monoxide exposure, can lead to
a progressive and permanent cerebral dysfunction. This process is believed to be due to the
direct effect of CO on neurons. A brain-demyelinating process results.
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Table 7. Carbon monoxide intoxication
Carboxyhemoglobin level, % Symptoms
0–5 Normal value
15–20 Headache, confusion
20–40 Disorientation, fatigue, nausea, visual changes
40–60 Hallucination, combativeness, coma, shock state
>60 Mortality > 50%
Table 8. Relation of hydrogen cyanide concentrations in
air and symptoms in humans
HCN concentration, ppm Symptoms
0.2–5.0 Threshold of odor
10 Maximum safe exposure
18–36 Slight symptoms (headache)
45–54 Tolerated for
1
2 −1h
100 Fatal – 1h
110–135 Fatal in
1
2 −1h
180 Fatal in > 10 min
280 Immediately fatal
More recently, neurons exposed to CO produce nitrous oxide and attract leucocytes,
a process suggesting that brain injury is related to inflammation.54−58 Cyanide toxicity
presents in a very similar fashion, with metabolic acidosis and obtundation in severe cases.
The degree of toxicity is again dependent on the concentration of HCN in the smoke
(Table 8). Diagnosis, however, is more difficult because cyanide levels are not always
readily available or reliable.
DIAGNOSIS
Thepersistenceofametabolicacidosisinthepatientwithadequatevolumeresuscitationand
cardiac output suggests the persistent carbon monoxide (or cyanide) impairment of oxygen
deliveryandutilization.AcarboxyhemoglobinlevelorpercentofhemoglobinboundtoCO
is obtained. However, other cell poisons cannot be excluded. Of importance is that arterial
oxygen tension, PaO2, will remain relatively normal because the chemical alteration of
hemoglobin by carbon monoxide will not affect the amount of oxygen dissolved in arterial
plasma.Therefore,thecalculatedPaO2 cannotbeusedasamarkerofadequateoxygenation.
Therefore, if there is a discrepancy between the measured PaO2 and measured oxygen
saturation, carbon monoxide toxicity is likely present until proved otherwise. However,
most times, O2 saturation of hemoglobin is calculated, not measured. It is also important to
recognize that COHgb looks like HgbO2 by color, and values of 5% or greater will lead to
a significant overestimation of oxygen saturation using a pulse oximeter.59−60
Ahighcarboxyhemoglobinalsoindicatesasignificantsmokeexposure,andtherefore,
a chemical burn to the airways is likely to be present. A low carboxyhemoglobin does
not always indicate a minimal smoke exposure because administration of oxygen at the
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Figure 2. Relationship of COHgb and O2 breathed.
The half-life of COHgb breathing room air is about 60
minutes, compared with 20 minutes breathing 100%
oxygen.
Table 9. Treatment of carbon monoxide and cyanide toxicity
Carbon monoxide – awake Carbon monoxide – obtunded Cyanide
High flow by mask oxygen
(FiO2 100%) until
carboxyhemoglobin < 10%
Intubate Cardiovascular support
100% oxygen via positive pressure
ventilation
Sodium nitrite only if not
responding and high
likelihood of diagnosis
HCN toxicity
Hyperbaria used if patient not
responding to 100% (specific
indications remain unclear)
Sodium thiosulfate
scene of the fire can displace some of the carbon monoxide before arrival in the emergency
department.Bloodcyanidelevelscanbemeasuredtomakethediagnosisofcyanidetoxicity.
Normal levels are less than 0.1 mg/L.
TREATMENT
Oxygen administration is required in any patient with an index of suspicion of carbon
monoxide toxicity. The extra oxygen provided will help displace the carbon monoxide from
hemoglobin (Table 9) (Figure 2).
The half-life of COHgb when breathing 100% high-flow oxygen is 20 minutes,
that is, the concentration of carboxyhemoglobin is reduced to approximately 50% every
20 minutes.54,56
Hyperbaric oxygen (2–3 atm) produces an even more rapid displacement and is most
usefulincasesofprolongedexposure,whenitismoredifficulttodisplacecarbonmonoxide
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from the cytochrome system.59 The drawback of hyperbaric oxygen use is the inability
to “get to the burn patient” during the crucial period of hemodynamic and pulmonary
instability. Hyperbaric oxygen is best used in cases in which the patient has severe neu-
rologic compromise with high carboxyhemoglobin, more than 50%, but no major burns
or severe pulmonary injury, and is not responding to high-flow oxygen with clearance of
symptoms.Thevastmajorityofcasescanbemanagedbysimplyusing100%oxygen.How-
ever, there remains a question of the development of a neurologic deficit with a high CO
exposure.
Endotracheal intubation and the use of 100% oxygen with mechanical ventilator as-
sistance are indicated for those patients with markedly impaired neurologic function and
high carboxyhemoglobin.
Cyanide management remains controversial. In general, cardiopulmonary support is
usuallysufficienttreatmentbecausetheliverviatheenzymerhodenasewillclearthecyanide
from the circulation. Sodium nitrite is used (300 mg intravenously over 5–10 minutes)
in severe cases, especially those in which a known diagnosis is made by blood levels.
Methemoglobin is produced in this reaction. Methemoglobin does not transport oxygen
and some hypoxia can develop. Ordinarily, thiosulfate is also given, which, in turn, binds
the cyanide to form thiocyanate. One should be reasonably sure of the diagnosis of cyanide
toxicity before giving sodium nitrite.61,62
Hydroxocobalamin, a vitamin B12 derivative found to actively chelate cyanide, is
often used in the prehospital management of smoke inhalation victims with a reported
considerable improvement in mortality.61
Smoke injury: gas versus particle phase
As described, a number of toxic compounds in smoke are considered to be involved in the
lung damage, especially in the airway injury.
Smoke is composed of 2 phases,6,50,63 a gas and a particle phase.
Thegasphasecontainsanumberofvolatilewater-solublecompounds,suchasacrolein,
chlorine, hydrochloric acid, sulfur compounds, as well as carbon monoxide, carbon diox-
ide, and cyanide gas.21,42 Large quantities of short-acting oxidants and oxidant precursors
are also present.31,64 These compounds have been reported to produce proximal airway
damage. The gas phase of smoke also contains unusually long-acting oxidants, which
can reach distal lung tissues. The particle phase of smoke is composed of carbon par-
ticles 0.1 to 10 μm in diameter31,64−66 on which are adhered many of the compounds
found in the gas phase along with heavy metals and other oxygen radical-producing com-
pounds and lipid-soluble compounds like the aldehydes. Some of the gas compounds
like phosgene can also bind to the carbon.63,67−69 Particle size and tidal volume deter-
mine their distribution in proximal versus distal lung.63−70 Once particles adhere to lung
tissue, the injury from adhered toxins, including oxidant release, can occur over hours
to days, resulting in progressive cellular injury and in severe injuries, mucus membrane
destruction.
A severe airway injury has been noted with wholesmoke exposure, characterized
by airway inflammation. Removal of the particles >0.3 μm in diameter nearly elim-
inates the airways injury,63,69 indicating that particles of >.3 μm cause the majority
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of the burn injury. Airway fluid lipid peroxide content is also very high with
wholesmoke exposure, suggesting an airway source for the oxidants and resulting oxidant
damage.63,68
Anassessmentoftheimportanceofthegasversustheparticlephasetothesmokeinjury
has only recently been studied as regards protection from the toxins. Numerous studies of
fire fighters at the Trade Center explosion have demonstrated chronic lung changes. With
nasalbreathing,thenasopharynxremovesthemajorityoftheparticles>5μmindiameter.70
However, with mouth breathing, particle deposition in airways and alveoli, is much greater
but again dependent on particle size and tidal volume.63,71−74 A number of investigators
have reported increased distal lung and tracheobronchial and distal lung particle deposition
with mouth breathing. For particles less than 4 μm in diameter, the greater the volume of
breathes, the greater the airway distribution.71,73 Mouth breathing is likely to occur in a
smoke victim because of the nasopharyngeal irritation of smoke, and most smoke injury
studies have bypassed the nasopharynx. An unconscious victim also will typically mouth
breathe. The degree of singeing of nasal hairs, often seen with smoke exposure, is caused
by the local heat from flames and not from the smoke itself. Therefore, the absence of heat
injury in no way rules out smoke exposure.
LUNG DAMAGE FROM SMOKE INHALATION
Thereareindeed2majorcomponentstoourknowledgeandtreatmentofthisinjuryprocess.
The first and most clinically relevant is the physiologic changes that occur and must be
managed clinically to obtain optimum outcomes.75−77 The second component relates to
the biochemical changes that are the cause of these physiologic changes.27,28 Both will be
discussed with the first component being a physiologic change following smoke inhalation
(Figures 3 and 4).
Figure 3. Upper-airways edema after
smoke inhalation. Note the erythema
and edema of supraglottic tissue and
cords. Progression of edema can lead to
obstruction.
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Figure 4. Facial burn (24
hours). Note the marked fa-
cial and oropharyngeal dis-
tortioncausedbytheresult-
ing tissue edema.
Physiologic changes
Upper airway injury
Pathophysiology
Direct-heat injury caused by the inhalation of air heated to a temperature 150◦C or higher
ordinarilyresultsinburnstotheface,oropharynx,andupperairway(abovethevocalcords).
Even superheated air is rapidly cooled before reaching the lower respiratory tract because
of the tremendous heat-exchanging efficiency of the oropharynx and nasopharynx.78−79
Heat and especially the chemicals in smoke produce an immediate injury to the airway
mucosa, resulting edema, erythema, and ulceration. Although these mucosal changes may
beanatomicallypresentshortlyaftertheburn,physiologicalterationwillnotbepresentuntil
the edema is sufficient to produce clinical evidence of impaired upper-airway patency. This
maynotoccurfor12to18hours.Thepresenceofabodyburnmagnifiestheinjuryindirect
proportiontothesizeanddepthoftheskinburn.80 Themassivefluidrequirementnecessary
to treat the skin burn is partially responsible, as are mediators released from the burned
skin. It is now recognized that epithelial cells in the pharynx respond by increasing mucus
production, which can then be found in the lower airways often in obstructive mucus clots.
Another compounding injury is any face or neck burn that will produce marked
anatomic distortion and, in the case of the deep neck burn, external compression on the
larynx. A more superficial burn causes massive external edema but may produce much less
mucosal edema and airway compromise. The local edema usually resolves in 4 to 5 days.
Thechemicalburntotheupperairwaysresultsinaspectrumofclinicalmanifestations
duringthisperiod.Attheveryleast,amucosalirritationwillpersistforseveraldayscausing
increased cough and mucus production.81−91
Asairwayinflammationandbronchialbloodflowincreasedovertheseveraldays,even
modest volume overload can markedly potentiate the airways edema. The combination of
the chemical lung burn and a body burn markedly potentiate the morbidity and mortality of
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eitherprocess.Ifinfectioncanbecontrolledandsecretionscleared,theacuteprocesswillre-
solveoverthenext7to10days.However,theriskofpulmonaryinfectionpersistsforseveral
weeks,extendingwellintotheinflammationperiod,asupperairwaysecretionsareaspirated.
The damaged ciliary function of the airways lining leads to an inability to clear se-
cretions and bacteria manifested by a tracheobronchitis.81−91 Bacterial colonization is in-
evitable. Characteristically with a severe injury, the damaged mucosa becomes necrotic at
3 to 4 days’ injury and slough. The increasingly viscous and copius secretions can lead to
increasing distal airway resistance, distal airway obstruction, atelectasis, and a high risk of
rapidly developing bronchopneumonia. With modest-to-severe injury, there will be mainly
evidence of erythema and edema of the mucosal surface.
Symptoms
Symptomsofobstruction,namely,stridor,dyspnea,increasedworkofbreathing,andeventu-
allycyanosis,donotdevelopuntilacriticalnarrowingoftheairwayispresent.Upperairway
noiseindicativeofincreasedturbulentairwayoftenprecedesobstruction.Theairwayedema
andtheexternalburnedemaprocesshaveaparalleltimecoursesothatbythetimesymptoms
of airway edema develop, external and internal anatomic distortion will be extensive.
Diagnosis
A history must be obtained regarding the nature of the burn, the presence of smoke, and the
patient’s initial neurologic status. Inspection of the oropharynx looking for soot or evidence
of heat or chemical injury should be done with every burn victim. Direct laryngoscopy is a
valuable method to determine whether an injury is present. Typically, erythema and edema
will be found. Repeat examinations will be needed if an injury is present and intubation
is not performed, because the process often progresses over the next 24 hours. Fiberoptic
bronchoscopy is also very useful and can be done very safely.79 This diagnostic test is
valuable for assessing an airway that is suspect or for evaluating the lung with a known
airway burn.
Treatment
A very important judgment decision must be made in the initial assessment as to whether
theinjuredairwaycanbemaintainedsafelywithoutanendotrachealtube.Whenindoubtof
whether progressive edema is likely, it is safest to intubate. These are the major categories
of patients at risk for airway compromise.54
1. Heat and smoke injury plus extensive face and neck burns:
This group invariably requires intubation.
2. Oral burn but no smoke injury:
These patients have difficulty controlling secretions as edema evolves. Early
intubationissafeapproachbecauseanatomicaldistortionofthemouthmakesintubation
at a later period very difficult.
3. Heat and smoke injury, no facial burn:
If there is no evidence of severe upper-airways edema, this group can be carefully
observed. The lack of a facial and mouth distortion makes it feasible to intubate later.
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Aerosolized adrenaline has also been found to be beneficial in decreasing the edema
process, improving airway patency. It is also beneficial, in both the nonintubated and in-
tubated patients, to maintain a semi-erect position if hemodynamically stable, to minimize
the airway and facial edema process. Edema forms much faster than it resolves, so early
preventative measures are important.83
If intubation is performed, the tube must be well-secured because it may be extremely
difficult to replace if it becomes dislodged, as the process of edema evolves. Anticipate
a 2- to 3-week period of upper-airway symptomatology as that is the time frame for re-
epithelization of the injured mucosa.
CHEMICAL BURN TO THE LOWER AIRWAYS
Pathophysiology
This aspect of inhalation injury is often an extension of the upper-airways injury just de-
scribed but is generally much more serious. Toxins contained in smoke as well as carbon
particlescoatedwithirritatingaldehydesandorganicacidscanresultininjurytobothupper
and lower airways. The location of injury will depend on the duration of exposure, the size
of the particles, and the solubility of gases. The lungs response to inflammation spills over
to systemic organs.
The components in smoke causing injury are defined as follows:
1. The gas phase, as described, contains a host of toxins, including carbon monoxide,
cyanide gas, acids, and aldehydes.84−88 Oxidants are also clearly present in the gas
phase.86 These agents produce local-airway injury. The vapors, in large part, are mucus
membrane irritants leading to intense bronchorrhea, bronchoconstriction, and airway
edema.Theprocessoftenpeaks24−36hoursafterinjury,althoughpatientswithpreexisting
airway reactivity disease can develop very early intense bronchoconstriction.21−24
2. The particles phase injury of smoke produces a severe injury. The degree of exposure to
thelungisdependentonparticlesizeandbreathingpattern.63−66Thedegreeofdeposition
in distal lung is accentuated by deeper breaths, as would be evident in a hypoxic patient
or a patient attempting to actively escape the insult. As opposed to the gas phase, which
is short-lived, the particulates can adhere to the mucosa and perpetuate the local tissue
injury.Particulateclearance,inturn,willbeimpededbytheimpairedmucociliaryaction
perpetuating the injury.32−54
Smoke from different environments varies dramatically in toxicity. Examples of ex-
tremely toxic smoke include smoke from burning automobile interiors, upholstery, and
chemical plants in which hydrocarbons are a major component.
Physiologic changes
There is a marked damage to the airways mucosa. The cell biologic effect will be described
later. With moderate-to-severe injuries, there is evidence of denudement of the mucosal
surface. Anatomically, erythema and edema are present (Figure 5–7). Histologically, there
is evidence of mucosal lining damage and peribronchial inflammation.
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Figure 5. Lower airways response to smoke exposure. Note
the presence of erythema and edema in airways encroaching
on the airways lumen. Addition of increased mucus can lead
to destruction.
Figure 6. Airwayliningat3days.Notetheinfiltration
of inflammatory cells around airway.
Symptoms
In the first several days after injury, remaining soot continues to be present in the airways
secretions. Diffuse rhonchi are usually present, once inflammation develops. Wheezing
persists. Continued coughing as well as the residual airways edema and bronchospasms
increase the work of breathing, which can lead to fatigue and hypoventilation. Secretions
then become tenacious and more difficult to clear. Rales compatible92−95 with an edema
processwillbenotedinthemostsevereairwaysinjuries.Evidenceofbronchitisiscommon,
followed by bronchopneumonia in a substantial number of patients.
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Figure 7. Airway lining at 5 days. Note the ab-
sence of airways epithelium and cilia severely im-
pairing immune defenses.
Figure 8. Reactive airways. Note that airways remain
hyperactive in the postinhalation injury period. Peri-
bronchial edema and inflammation is evident.
Diagnosis
Diagnosis of severity of injury is based on the course of the disease process rather than
on initial findings from fiberoptic bronchoscopy, which basically indicate only that an
injury is present. Chest radiographs during this initial period show, in general, significant
underestimation of the severity of lung damage because the injury is usually confined to
the airways.96 Alveolar injury is seen only in severe cases.
Clinical evidence of continued respiratory compromise namely, dyspnea, tachypnea,
diffuse wheezing, and rhonchi precede radiographic changes (Figures 8–10). The evi-
dence on radiography of lung damage is usually that of either diffuse atelectasis, pul-
monary edema, or bronchopneumonia. Altered gas exchange is reflected in blood-gas anal-
ysis, and the assessment of changes in sputum characteristics is a useful parameter to
monitor.
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Figure 9. Severe airways injury from smoke. Note the
case of airways mucosa, which can break up plugging
distal airways.
Figure 10. Severe tracheobronchiolitis evolving to bilateral
nosocomial pneumonia. Note the diffuse nature of the respira-
tory dysfunction.
Treatment
The clearance of soot, mucopurulent exudate, mucus plugs, and sloughing mucosa is es-
sential to avoid progression of the lung injury. An endotracheal tube may be necessary if
the patient is fatiguing and if gas exchange is worsening. Continued readjustments in tidal
volume, rate, and positive end-expiratory pressure are necessary to maintain gas exchange
while minimizing barotraumas. Sedation (narcotic-induced or paralysis) may be necessary
if the patient’s spontaneous ventilatory attempts further impair lung function while on ven-
tilator support. Bronchodilators, by aerosols, are also very helpful, along with frequent
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changes in position postural drainage. High-frequency percussive ventilation has also been
shown to be effective at clearing secretions.97 Bronchial lavage has yet to be shown to be
an effective method of removing adherent soot particles. Mucolytic agents can be effective
if used cautiously to avoid further airways inflammation.
Infection surveillance is crucial during this early period to detect the onset of bacterial
bronchitis before the development of pneumonia. Sputum smears monitoring of the charac-
terofthesputumareusefulearlyguides.Systemicantibioticsarenotgivenprophylactically
but initiated when a bacterial process becomes evident.
In addition, there is a marked increase in airways reactivity resulting in asthma-like
symptoms.Airwayscollapseismuchmorelikelywithclotsofmucusandneutrophilsbeing
released from the upper airways into reactive lower airways.
In severe cases, the airway mucosa separates and pieces plug distal airways leading
to a rapidly developing pulmonary dysfunction with increasing airways-resistant and shunt
fraction.
TRACHEOBRONCHIOLITIS AND NOSOCOMIAL PNEUMONIA
Pathophysiology
Theterm“nosocomialinfection”referstothatwhichdevelopsinahospitalwithnoevidence
of lung infection present on admission, that is, it is hospital-acquired. Burn patients with a
combinationofinhalationinjuryandamajorbodyburnhavethegreatestriskofpneumonia,
with a rate exceeding 50%.78−81 The high incidence is due to the presence of virulent
organisms in the environment and the immunosuppressed state of the burn patient with
lung damage. Lung bacterial clearance is significantly impaired in the presence of a burn
and inhalation injury. The major impairments in immune dysfunction responsible for lung
infections are described.
Colonization
Nearly 100% of major burn patients with a smoke inhalation respiratory problem have
colonized their oropharynx with pathogens. There are a number of routes and events where
colonization occurs.90−93
Impaired cough
Impairment of this reflex is a common occurrence. A decrease in the state of consciousness
markedly suppresses the need of narcotics for pain control. The impairment is caused by
the muscle weakness from catabolism. Any aspirated, infected oral secretions then have the
opportunity to proliferate.
Impairment of mucociliary action
The airways are lined with ciliated mucus-coated epithelia that beat toward the pharynx,
thereby assisting in the continued clearance of particles and microorganisms. This is par-
ticularly important to the smaller airways that are less effectively cleared by coughing. The
ciliary action is directly injured by heat and chemicals in inhaled smoke.8,32
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Airway plugging
Thecombinationoftenacioussecretions,mucosalsloughing,andimpairedclearanceleadto
frequentpluggingofsmall-andmedium-sizedairwayscausingatelectasisandtheincreased
risk of infection.98−100
Impairment of alveolar macrophage function
Bacteria or particles deposited in the alveoli are rapidly phagocytized by the alveolar
macrophage, which destroys them by direct killing via oxygen radical release. A num-
ber of factors in the burn patients will impair macrophage function. Inhalation anesthetics,
inhalation injury, malnutrition anemia, and hypoxia will impair the macrophage function,
thereby increasing the risk of lung infection.
Impairment of containment
The postburn immunodeficiency state involves both the cellular and humoral components
ofresistance,whichwillimpairtheabilityofthelungdefensestocontaininfection.Another
majorfactorthatimpairsthecontainmentprocessisincreasedlungwater.Themovementof
edemafluidallowsarapidspreadofbacteriatouninvolvedareasbothasvehicleforcarrying
bacteria and as an impairment of the sequestration and containment process. Airways and
alveolar edema will be present with severe smoke injury.
Excess use of antibiotics
The burn patient develops a sepsis syndrome as a result of the inflammatory response to
injury. This process makes it difficult to diagnose a superimposed infection often leading
to an excessive use of antibiotic and the development of resistant organism.101
Biologic and biochemical changes
Upper-airway injury
The pharynx is exposed to both phases of smoke; larger carbon particles, greater than
5 μm in diameter, are deposited in the oropharynx. The key biologic components of the
upper-airway tissue damage are described in Table 10.
Table 10. Biologic changes
in upper airway with smoke
injury102−111
• Destruction of epithelial layer
• Increased vascular permeability
• Increased edema formation
• Increased neuron stimulation
• Increased mucus production
• Tissue inflammation
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Theupper-airwayepitheliumhassimilarbarrierfunctionsastheepidermisoftheskin.
Loss of this barrier will expose the submucosa to smoke particle toxins and local inflam-
mation mediators that can increase the submucosal microvascular permeability. Typically,
particles landing in the airway, in the presence of an intact epithelium, are cleared rapidly
ending up in the glottis and swallowed. Particles penetrating will need to be cleared by
macrophages.102
The columnar epithelial begins to denude at about 30 minutes after smoke
exposure.101−111 Toxins that then penetrate will directly increase the local-tissue damage
and then the damage occurs from inflammation. Gas-phase toxins are typically cleared on
contact with an intact epithelium.
Heat and chemical then increase submucosal vascular permeability.78−83 This process
increases submucosal fluid content78−83 resulting in edema. It requires about 3 weeks for
the damaged epithelium to repair.
A marked increase in tissue inflammation then occurs with the sequestration of a large
number of neutrophils, which then will reside in mucus.106,107 Mediators of inflammation
self-perpetuate in the mucosa and submucosa24−29 although the increased production of
airway mucus is an attempt at protection. This upper-airways mucus has been shown to end
up in lower airways along with trapped neutrophils leading to thick lower-airway plugs.81,88
Theupperairwaysvasculatureiscontrolledbyadrenergic,cholinergic,andpeptidergic
nervousmechanism.85,103−105 Sympatheticnervesreleasenorepinephrineandneuropeptide
Y, both of which are constrictor agents. Parasympathetic nerves release acetylcholine and
usually vasoactive intestinal polypeptide, both of which are vasodilators, the latter being
the longer-lasting. These motor nerves are controlled by many reflex inputs. Activation of
pulmonary C-fiber receptors by irritants and inflammatory mediators also causes a power
vasodilatation. Chemoreceptor reflexes also influence airway vascular tone. Sensory upper
nerves in the airway mucosa are responsible for local axon reflexes in response to irritants
and inflammatory mediators. These nerves contain neuropeptides such as substance P,
neurokinins A and B, and calcitonin gene-related peptide. All these neuropeptides are
powerful vasodilators.103−105
Vasodilation in the presence of an already increased chemical-induced microvascular
permeability will markedly accentuate the rate of submucosal edema formation.
The bronchial system
With chemical damage, the ciliated epithelium separates from the basement membrane
resulting in an instantaneous experiment in immune defenses. In addition, there is a marked
increase in bronchial blood flow to the injured airways. Edema rapidly develops in the
submucosal space. This edema process occurs in airways as far as the chemical exposure
occurs.Theedema,inturn,maneuverstheairwayslumenresultinginphysiologicalteration
inairflow.Onekeycomponentisamarkedinflammatoryresponseleadingtoalargenumber
of white cells that mix with the surface mucosa leading to thick mucus.
There are a number of pathways that are involved with the bronchial edema and bron-
choconstriction. One such mechanism is the stimulations of sensory nerves in the airway. A
group of agents that are described generally as the neuropeptides are involved.112−114 The
neuropeptidesproducedinthesubmucosaafterairwayinjuryarepotentbronchoconstrictors
and can increase blood flow and alter permeability.38−41 The normal mucosal production
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Figure 11. Neuropeptides and airway changes. Note the
lossofneutralendopeptidase(NEP)activityduetoepithe-
lial damage, increases neuropeptide activity.
of neutral endopeptidases (NEP) is responsible for neutralizing these toxic agents. Loss of
NEP by mucosal damage by smoke will lead to an accentuated neuropeptide response.
Restorationofcontrolofpotentneuropeptidesrequirestherestorationofcolumnarep-
itheliumwithNEPproduction,whichexplainstheextensiveperiodofairwayshyperactivity
after smoke inhalation injury (Figure 11).112−114 Activation of clotting cascade also leads
to increased fibrin production finding its way into the plugs that occlude distal airways.
A number of inflammatory cascades also evolve, leading to airway injury. The chemical
components in smoke initiate airway inflammation. Prostanoids and leukotrienes are also
released especially from mast cells accentuating bronchoconstriction.115,116
Oxidants or oxygen-free radicals are present in smoke itself and are also produced
by chemical reactions in the smoke with oxidants lasting for minutes instead of seconds.
Excess oxidants produce a number of responses.31,32,45,45,86−81
First oxidants act on the airways mucosa causing cell membrane changes in the lipid
component of the membrane. The lipid peroxidation process can be destructive to cell
membrane permeability. A release of lipid peroxidation by-products has been shown to
be present in lung tissue and lung fluid after smoke exposure. Oxidants will also lead
to the activation of inflammation through cytokine release from inflammatory and mast
cells, which in turn, leads to further oxidant release and damage.45,45 Local-airway vascular
permeability can be increased. The extraordinary high bronchial blood flow with altered
permeability can lead to a rapid production of submucosal edema. In addition to oxidant
release, there is a marked decrease in antioxidant levels, increasing the risk of oxidant
damage.86,81 A number of antioxidants delivered in an aerosol form have been shown to
attenuatethesmoke-inducedinjury.117,118 Unfortunately,noantioxidantaerosoliscurrently
being used as a standard approach to inhalation injury. Another variable, as mentioned,
participating in the process is the 10- to 20-fold increase in bronchial blood flow after
smoke exposure. This response results in a large increase in airways edema. In addition,
the high blood flow is connected to the pulmonary microvascular blood flow allowing for
a rapid distribution of cytokines, oxidants, and so on, from the airways injury to more
peripheral parts of the lung including reaching the alveolar capillary membrane.119,120
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Neutrophil adherence to the mucosal layer is a major component. The systemic organ
damage, seen with smoke injury, can be in part explained by the systemic circulation
carrying proinflammatory mediators via the lung through the bronchial and pulmonary
vasculature to systemic organs.117
Alveolar injury
There are a number of vascular changes that occur after smoke injury. Pulmonary vascular
resistance is significantly increased by 12 hours after injury, indicating a circulating medi-
ators’ response. The increase in venous resistance increases microvascular pressure further
accentuating the degree of a capillary leak.118,121
The increase in neutrophil adherence on the alveolar capillary membrane results in a
factory for protease and oxidant release. This response is documented by the presence of
the increased proteases and oxidant by products in fluid form from the distal lung.121,122
There is definitely an increase in alveolar fluid after severe smoke inhalation injury. How
much of the fluid is run down from airway bronchorrhea or increased alveolar capillary
permeability is difficult to distinguish.
In addition to alveolar flooding, there is also an increase in alveolar collapse as a result
of lack of surfactant causing a more rapid alveolar collapse and atelectasis. Atelectasis is a
common component of smoke injury.123
Treatment
At the present time, treatment for the biologic and biochemical changes that occur in the
alveolusremainsrespiratorysupportsagainstthedeleteriousphysiologicchanges.Anumber
of antioxidants and anti-inflammatory blockers have been shown to decrease mucosal and
alveolar edema and atelectasis. These include a variety of antioxidant aerosols, cytokine
inhibitors, and neutrophil-adherence inhibitors.118−121
Improvement of pulmonary pathology has been demonstrated with this variety of
approaches. Currently, these approaches have not been adopted as clinical modulators but
remain mainly as research tools to study the disease process.
SYSTEMIC RESPONSE TO SMOKE INHALATION
There are well-described systemic responses to a smoke inhalation injury. These responses
are most pronounced in the presence of a body burn where burn mortality rate is markedly
increased in the presence of a smoke inhalation injury. A moderate smoke inhalation injury
has been reported to decrease initial systemic oxygen delivery and oxygen consumption
mainly by elevated carboxyhemoglobin levels, as well as a recognized decrease in cardiac
functions.124,125 However, this response is followed by an increase in systemic oxygen
consumption, when COHgb is removed, as a hypermetabolic state occurs in response to
the lung injury. During this time period, there is a selective decrease in blood flow to the
intestine and pancreas potentially leading to future organ failure especially from bacterial
translocation.Theincreasedbloodflowlikelyoccurstosofttissuesandmuscle.Theprocess
ofselectivechangesinbloodflowislikelydrivenbyinflammatorymediators.126 Inaddition,
275ePlasty VOLUME 8
systemic fluid requirements are increased as also the evidence of a transient change in
systemic vascular permeability in soft tissues, which is similar to a septic response.127,128
This effect is not due to carbon monoxide or cyanide but is likely the systemic response to
mediators from the lung inflammatory process.
Anincreaseinoxidantstress,asmeasuredbymarkersofthelipidperoxidationprocess,
is noted in liver, kidney, and blood levels in several studies.129−134 In addition, tissue an-
tioxidant activity is decreased likely due to increased consumption by the increased oxidant
activity. The systemic effect appears quite transient, lasting 24 to 48 hours in the absence
of a burn.
The major cause of death today from burn injury is respiratory failure. Pneumonia
is a common complication. However, there are significant early changes in physiology.
First, studies have shown that the combined injury leads to a greater than 50% increase in
systemic oxygen consumption compared with a burn alone.125,128,135 Second, early fluid
requirements are increased over 100% in the initial resuscitation period suggesting that
there is a further change in vascular permeability in both burn and nonburn tissue from
the lung injury. In addition, burn edema is markedly increased with the presence of smoke
inhalation. The systemic changes are caused by the particle phase of smoke because the
removalofparticleswithsmokeexposuretojustthegasphasepreventstheaccentuatedburn
response. The degree of increased burn-tissue edema is dependent on the degree of airways
injury, the greater the smoke insult, the greater the burn edema.127 Carbon monoxide and
cyanide do not appear to play a role.
Interestingly,oxygenconsumptionhasbeenreportedtobeoxygen-deliverydependent
with the combination injury as opposed to a burn alone, increasing the development of
tissue hypoxia. The inability to extract more oxygen from hemoglobin, when needed, is a
typical response to sepsis, ARDS, or any generalized inflammatory process again indicat-
ing the close relationship between systemic and lung physiology in the presence of lung
inflammation.129 These responses are clearly inflammation-induced, from the smoke injury
process.
As previously described, oxygen radicals are involved in the systemic response.132−136
Smoke-inducedradicalscanbelong-livedeitherprovidingtheopportunitytoproducedirect
systemic effects or an alternate explanation would be the release of systemic proinflamma-
tory cytokines that would then produce systemic inflammation.
Of interest is the presence of a marked increase of by-products of lipid peroxidation
in systemic tissues, caused by oxidant damage to all membranes in burn tissue edema fluid
from the combined injury compared with burn alone. A similar process is seen in the lung
with the combined injury.132,136
One hypothesis, backed up by research data, is that this increased overall oxidant
activitycanbeattenuated.Deferoxaminestarch,anironchelatorgiveninresuscitationfluid
attenuates the systemic response to free iron which activates oxygen radical production to
smoke injury. The same protection is provided when deferoxamine starch is delivered to the
smoke-exposed lung by aerosol.137 These findings would indicate that the lung itself is the
source of the free iron. Interestingly deferoxamine, a small molecule provided alone, has
no effect indicating that a large starch complex is needed, which likely has a much longer
half-life on the airways mucosa.
Of importance is the fact that maneuvers that are, as previously described, used to
decreasethesmoke-inducedlunginjurywillsignificantlyattenuatethedeleterioussystemic
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effects.Atpresent,however,itisnotpossibletoaccuratelydistinguishwhethertheincreased
morbidity and mortality of the combined injury is due primarily to the lung injury inducing
severe systemic changes or vice versa. However, evidence, as described, would favor the
hypothesis that the inflammatory process in the lung, caused by smoke exposure, is the
driving force in the response.
SUMMARY
Smokeinhalationinjuryisacomplexmultifacetedlungandsystemicdiseaseprocess,which
untilrecently,hasbeenpoorlyunderstood.Itwasrecognizedasamajorkillerofburnvictims
intheearly1900s.Butimprovedrespiratorysupportmodalitiesdevelopedinthe1960swere
needed before the prolonged course of injury was appreciated, namely, the delayed mucosal
and alveolar damage. With ARDS being defined, the lung as an inflammatory organ began
to be appreciated.
The toxins in smoke began to be better defined through the 1970s. Of particular
importance was the recognition that these chemicals, including oxidants, attached to smoke
particles where, after being deposited in the large and small airways, they initiated an
injury process. Finding particles in the lungs through bronchoscopy became a marker for a
delayed progressive process. Carbon monoxide and cyanide are carried in the gas phase to
the alveolus, where they are absorbed through the alveolar capillary membrane.
The physiologic response to smoke exposure was further identified in the past 2
decades. Small airway obstruction, by mucus and inflammatory cell casts, is quite char-
acteristic whereas sloughing of mucosa is evident in more severe cases. Increased airways
reactivity for prolonged time periods is characteristic. Increased work of breathing alveo-
lar flooding or collapse with resulting impaired gas exchange is also characteristic, as is
increased pulmonary infection.
More recent advances have focused on the lungs’ inflammatory reaction to the smoke
insult. A host of mediators are involved including proinflammatory cytokines, neuropep-
tides, activated clotting factors, and very importantly, oxidant release. Oxidants are com-
ponents of smoke itself, produced by reactions in smoke and again produced by the inflam-
matory process. New advances in the understanding of the biochemical changes present in
the lung responsible for injury has yet to evolve into new treatment modalities, reflecting
the typical lag time between science and clinical practice.
Several antioxidant aerosols have been shown to be experimentally effective. Aerosol
development seems to be a logical way to improve therapy, which focuses on physiologic
support. Finally, the recognition that a smoke inhalation injury is also a systematic injury
process adds valuable information on management and better answers the question as to
why the mortality rate for the combined smoke and burn injury is so much greater, than
either one alone.
Withourever-increasingunderstandingofthebiologyofthisinjury,webecomecloser
to developing treatment modalities focused on lung inflammation in addition to current
physiologic support measures.
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